Valeo Health passes one million orders and shares health risk data from UAE users

The UAE and Saudi Arabia-based at-home healthcare platform is publishing anonymised health data from its user base to mark the milestone.

Staff Writer
Valeo Health
Image: Valeo Health

Article summary

AI Generated

Valeo Health has reached 1 million orders across the UAE and Saudi Arabia five years after launching. Anonymised data from its user base shows that 66% of first-time testers had high cholesterol, and most users who retested saw measurable improvements in key health markers.

Key points

  • Valeo Health hit 1 million orders across UAE and Saudi Arabia
  • 66% of first-time users tested positive for high cholesterol
  • Users on guided programmes lost an average of 20% body weight

Subscribe to our free newsletter to continue reading.

Newsletters

Valeo Health, a UAE, Saudi Arabia and Qatar-based platform for at-home testing and guided health programmes, has processed 1 million orders since its founding five years ago. To mark the anniversary, the company has released findings drawn from anonymised data across its user base.

The numbers suggest most people don’t know they carry a health risk until they test for one. Among first-time users, 66 per cent were found to have high cholesterol and 33 per cent had elevated HbA1c levels. Separately, 75 per cent of users who enrolled in Valeo’s weight management programmes had a BMI above 25 at the start.

The outcomes data is more encouraging. Of users who retested, 47.6 per cent saw cholesterol levels improve. Those on a guided weight loss programme lost an average of 20 per cent of body weight. And 47 per cent saw HbA1c improve within 3–4 months on Valeo’s Berberine+ programme. The company says 42 per cent of users also improved their Longevity Score upon retesting.

“Nearly one million health orders later, the data tells a clear story: many people are living with health risks they don’t know they have. The encouraging part is that when people understand their health and take action, those markers improve. The biggest risk isn’t getting a bad result – it’s never testing in the first place,” Nadin Karadag, COO & Co-Founder of Valeo Health said in a statement.

Over the past year, Valeo has added doctor-guided peptide therapy, newborn care, postpartum wellness, hair growth treatment and advanced functional testing to its offering, alongside expanded corporate health solutions.

“We’ve been focused on longevity for the past five years, long before it became a mainstream healthcare conversation. The launch of the Dubai Longevity Authority reflects a growing shift toward prevention and healthy ageing. Our own data shows that when people receive personalised support, they can meaningfully improve their long-term health.” “These outcomes are powered by a combination of AI-driven health insights, wearable integration, continuous monitoring and guidance from our doctors, nutritionists and functional medicine experts delivered through the Valeo Health App,” Sundeep Sahni, CEO & Co-Founder of Valeo Health added.

Advertisement

More News